$23.5 MILLION TO CONVENTUS ORTHOPAEDICS (Orthopedics This Week)
Conventus Orthopaedics, Inc. will have lots more equity to grow with these days…the company has just finished a $23.5 million equity round of funding. All of the new financing comes from existing investors.
As indicated in the November 4, 2015 news release, “Conventus’ innovative 3-dimensional fracture management platform technology allows surgeons to achieve reliable 3D fixation in a less invasive manner for a variety of periarticular fractures throughout the body. Conventus will use the funding to support the commercial launch of the Conventus Cage, a FDA-cleared treatment for proximal humerus (PH), distal radius (DR), and proximal radius (PR) fracture repair. The Conventus Cage’s less invasive surgical technique and versatility enable secure fixation and stable 3-dimensional fracture repair where existing techniques have been shown to have limitations. The funding will also support R&D for new indications such as conditions in the lower extremity.”
Conventus Chief Executive Officer Paul Buckman said, “The fact that 100% of this equity funding came from current Conventus investors serves as validation that the Co...
